These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25605009)

  • 1. Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis.
    Xiao X; Liu Z; Wang R; Wang J; Zhang S; Cai X; Wu K; Bergan RC; Xu L; Fan D
    Oncotarget; 2015 Feb; 6(5):3225-39. PubMed ID: 25605009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer.
    Chen X; Wu Y; Gu J; Liang P; Shen M; Xi J; Qin J
    Biofactors; 2020 Jul; 46(4):620-628. PubMed ID: 32078221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
    Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
    J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion.
    Myoung H; Hong SP; Yun PY; Lee JH; Kim MJ
    Cancer Sci; 2003 Feb; 94(2):215-20. PubMed ID: 12708500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
    Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
    BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer.
    Lin J; Feng J; Jin Y; Yan Z; Lai Z; Peng J
    Oncol Rep; 2016 Dec; 36(6):3568-3576. PubMed ID: 27779683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
    Kim BR; Kang MH; Kim JL; Na YJ; Park SH; Lee SI; Kang S; Joung SY; Lee SY; Lee DH; Min BW; Oh SC
    Oncol Rep; 2016 Nov; 36(5):2601-2608. PubMed ID: 27633042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor.
    Shen K; Liang Q; Xu K; Cui D; Jiang L; Yin P; Lu Y; Li Q; Liu J
    Biochem Pharmacol; 2012 Aug; 84(3):320-30. PubMed ID: 22580051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.
    Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.